Oncothyreon Inc.’s(ONTY) MACD indicator has entered into bearish territory with a reading of -0.0291. The Zacks #4 Rank (“Sell”) stock has decreased more than 2% to $5.07 in afternoon trade. The full-year Zacks Consensus Estimate is currently pegged at a loss of 64 cents per share, which has worsened by 16 cents over the past 2 months.
“ONTY” Free Stock Analysis: Buy? Sell? Hold?
Zacks Investment Research